Role of Membrane Lipids in the Regulation of Erythrocytic Oxygen-Transport Function in Cardiovascular Diseases
Table 1
The change in saturation ratio () of individual phospholipid fractions in erythrocytic membranes of patients with stable angina (SA) and SA with hypertension (HT) on the background of treatment (means ± SD).
Variants of experiments
PC, µg /mg
PEA, µg /mg
SM µg /mg
PS µg /mg
PI µg /mg
DAG µg /mg
FFA µg /mg
Donors
1.05 ± 0.021
1.3 ± 0.038
1.7 ± 0.021
1.2 ± 0.023
1.2 ± 0.021
1.95 ± 0.022
1.1 ± 0.02
Patients with SA before treatment
1.65 ± 0.06
2.86 ± 0.069
3.23 ± 0.055
1.8 ± 0.051
2.34 ± 0.056
2.71 ± 0.69
2.26 ± 0.094
Patients with SA+HT before treatment
1.77 ± 0.067
3.92 ± 0.066
3.84 ± 0.05
2.24 ± 0.044
2.87 ± 0.058
2.89 ± 0.061
3.21 ± 0.062
Patients with SA after treatment
1.29 ± 0.063
2.09 ± 0.082
2.58 ± 0.075
1.49 ± 0.06
1.62 ± 0.066
2.45 ± 0.089
1.58 ± 0.076
Patients with SA+HT after treatment
1.45 ± 0.047
3.02 ± 0.079
3.26 ± 0.026
1.93 ± 0.078
2.64 ± 0.079
2.41 ± 0.043
Reliability in relation to donors’ indicators. Reliability in relation to pretreatment indicators at .
